Carey Macrury

Stock Analyst at Canaccord Genuity

(2.44)
# 779
Out of 5,275 analysts
15
Total ratings
42.86%
Success rate
51.80%
Average return
7 Stocks
Name Action Price Target Current % Upside Ratings Updated
Iamgold
Upgrades: Buy
8 11
5.62 86.83% 2 Oct 22, 2024
Gatos Silver
Downgrades: Hold
n/a
n/a n/a 2 Oct 22, 2024
Aptose Biosciences
Maintains: Buy
5850 3600
2.93 122766.89% 1 Mar 27, 2023
Newmont
Upgrades: Buy
53 55
43.8 25.57% 6 Mar 14, 2023
Royal Gold
Upgrades: Buy
151 140
149.9 -6.6% 2 Jun 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Speculative Buy
18 15
5.95 143.7% 1 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 110
98.32 11.88% 1 Feb 23, 2021